CANN
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
4.44M
CHSYF
Price
$1.35
Change
-$0.17 (-11.18%)
Updated
Aug 1 closing price
Capitalization
4.46B
Interact to see
Advertisement

CANN vs CHSYF

Header iconCANN vs CHSYF Comparison
Open Charts CANN vs CHSYFBanner chart's image
TREES
Price$0.04
Change-$0.00 (-0.00%)
Volume$116.67K
Capitalization4.44M
China Medical System Holdings
Price$1.35
Change-$0.17 (-11.18%)
Volume$1K
Capitalization4.46B
CANN vs CHSYF Comparison Chart in %
Loading...
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANN vs. CHSYF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANN is a Hold and CHSYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CANN: $0.04 vs. CHSYF: $1.35)
Brand notoriety: CANN and CHSYF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CANN: 54% vs. CHSYF: 52%
Market capitalization -- CANN: $4.44M vs. CHSYF: $4.46B
CANN [@Pharmaceuticals: Generic] is valued at $4.44M. CHSYF’s [@Pharmaceuticals: Generic] market capitalization is $4.46B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANN’s FA Score shows that 0 FA rating(s) are green whileCHSYF’s FA Score has 1 green FA rating(s).

  • CANN’s FA Score: 0 green, 5 red.
  • CHSYF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHSYF is a better buy in the long-term than CANN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANN’s TA Score shows that 4 TA indicator(s) are bullish while CHSYF’s TA Score has 0 bullish TA indicator(s).

  • CANN’s TA Score: 4 bullish, 5 bearish.
  • CHSYF’s TA Score: 0 bullish, 3 bearish.
According to our system of comparison, CANN is a better buy in the short-term than CHSYF.

Price Growth

CANN (@Pharmaceuticals: Generic) experienced а -1.76% price change this week, while CHSYF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHSYF($4.46B) has a higher market cap than CANN($4.44M). CANN YTD gains are higher at: 127.000 vs. CHSYF (45.052). CHSYF has higher annual earnings (EBITDA): 2.05B vs. CANN (619K). CHSYF has more cash in the bank: 5.97B vs. CANN (245K). CANN has less debt than CHSYF: CANN (17.4M) vs CHSYF (748M). CHSYF has higher revenues than CANN: CHSYF (7.86B) vs CANN (14.5M).
CANNCHSYFCANN / CHSYF
Capitalization4.44M4.46B0%
EBITDA619K2.05B0%
Gain YTD127.00045.052282%
P/E RatioN/A14.10-
Revenue14.5M7.86B0%
Total Cash245K5.97B0%
Total Debt17.4M748M2%
FUNDAMENTALS RATINGS
CANN vs CHSYF: Fundamental Ratings
CANN
CHSYF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9943
PRICE GROWTH RATING
1..100
3841
P/E GROWTH RATING
1..100
10073
SEASONALITY SCORE
1..100
5016

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHSYF's Valuation (15) in the null industry is somewhat better than the same rating for CANN (67). This means that CHSYF’s stock grew somewhat faster than CANN’s over the last 12 months.

CHSYF's Profit vs Risk Rating (94) in the null industry is in the same range as CANN (100). This means that CHSYF’s stock grew similarly to CANN’s over the last 12 months.

CHSYF's SMR Rating (43) in the null industry is somewhat better than the same rating for CANN (99). This means that CHSYF’s stock grew somewhat faster than CANN’s over the last 12 months.

CANN's Price Growth Rating (38) in the null industry is in the same range as CHSYF (41). This means that CANN’s stock grew similarly to CHSYF’s over the last 12 months.

CHSYF's P/E Growth Rating (73) in the null industry is in the same range as CANN (100). This means that CHSYF’s stock grew similarly to CANN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANNCHSYF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
9%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
9%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
11%
View a ticker or compare two or three
Interact to see
Advertisement
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DIVI37.070.33
+0.90%
Franklin Intl Core Div Tlt Idx ETF
DJAN42.030.08
+0.18%
FT Vest US Equity Dp Bffr ETF Jan
PSMR29.220.05
+0.18%
Pacer Swan SOS Moderate (April) ETF
SEF31.28-0.21
-0.68%
ProShares Short Financials
TSMX45.11-1.18
-2.55%
Direxion Daily TSM Bull 2X Shares

CANN and

Correlation & Price change

A.I.dvisor tells us that CANN and CVSI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANN and CVSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANN
1D Price
Change %
CANN100%
+2.15%
CVSI - CANN
23%
Poorly correlated
N/A
MEDIF - CANN
21%
Poorly correlated
-2.58%
CNTMF - CANN
14%
Poorly correlated
-6.00%
CAIHF - CANN
12%
Poorly correlated
N/A
BIOGY - CANN
9%
Poorly correlated
N/A
More

CHSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHSYF has been loosely correlated with CNADF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CHSYF jumps, then CNADF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
CNADF - CHSYF
38%
Loosely correlated
N/A
SBFM - CHSYF
30%
Poorly correlated
-3.95%
SXTC - CHSYF
23%
Poorly correlated
+2.52%
TKNO - CHSYF
22%
Poorly correlated
+4.84%
CANN - CHSYF
7%
Poorly correlated
+2.15%
More